Cynthia M Stonnington
Affiliation: Mayo Clinic
- Interpreting scan data acquired from multiple scanners: a study with Alzheimer's diseaseCynthia M Stonnington
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, UCL, London, UK
Neuroimage 39:1180-5. 2008..Similar analyses in other multi-scanner data-sets could be used to justify the pooling of data when needed, such as in studies of rare disorders or in multi-center designs...
- Fibrillar amyloid correlates of preclinical cognitive declineCynthia M Stonnington
Department of Psychiatry and Psychology, Mayo Clinic in Arizona, Scottsdale, AZ, USA Electronic address
Alzheimers Dement 10:e1-8. 2014..It is not known whether preclinical cognitive decline is associated with fibrillar β-amyloid (Aβ) deposition irrespective of apolipoprotein E (APOE) ε4 status...
- Somatization is associated with deficits in affective Theory of MindCynthia M Stonnington
Department of Psychiatry and Psychology, Mayo Clinic, Arizona, United States
J Psychosom Res 74:479-85. 2013..To determine whether deficits in mental representation of emotion may constitute a mechanism for somatization...
- Anxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriersCynthia M Stonnington
Dept of Psychiatry and Psychology, Section of Biostatistics, and Dept of Neurology, Mayo Clinic, Arizona, USA
J Neuropsychiatry Clin Neurosci 23:294-9. 2011..The association of executive-functioning difficulties and anxiety appears more likely to occur in persons who are most at risk for subsequent cognitive decline...
- Predicting clinical scores from magnetic resonance scans in Alzheimer's diseaseCynthia M Stonnington
Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, AZ, USA
Neuroimage 51:1405-13. 2010..RVR offers a novel way to measure interactions between structural changes and neuropsychological tests beyond that of univariate methods. In clinical practice, we envision using RVR to aid in diagnosis and predict clinical outcome...
- Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriersCynthia M Stonnington
Division of Adult Psychiatry, Mayo Clinic, Scottsdale, AZ 85259, USA
J Clin Psychiatry 70:1379-84. 2009..To examine cognitive effects of pharmacologically induced somnolence in cognitively normal carriers and noncarriers of the apolipoprotein E (APOE)-epsilon4 allele, a common Alzheimer's disease susceptibility gene...
- Confirming psychogenic nonepileptic seizures with video-EEG: sex mattersKatherine H Noe
Department of Neurology, Mayo Clinic, Phoenix, AZ, USA
Epilepsy Behav 23:220-3. 2012..PNES are not only less common in men, but also more challenging to recognize in the clinic, and even when suspected more difficult to confirm with vEEG...
- Automatic classification of MR scans in Alzheimer's diseaseStefan Kloppel
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK
Brain 131:681-9. 2008..Thirdly, the method is robust and can be generalized across different centres. This suggests an important role for computer based diagnostic image analysis for clinical practice...
- Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important?Erika Driver-Dunckley
Dept of Neurology, Parkinson s Disease and Movement Disorder Center, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85251, USA
Psychosomatics 52:337-45. 2011..Psychogenic non-epileptic seizures (PNES) and psychogenic movement disorders (PMDs) are common in neurology practice, yet it is not established whether clinically relevant differences between these two groups exist...
- Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive agingDona E C Locke
Department of Psychiatry and Psychology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
J Clin Exp Neuropsychol 33:937-43. 2011..We encourage investigators involved in longitudinal studies to consider causes for missing data, especially when secondary to participant refusal...
- Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal studyDona E C Locke
Department of Psychiatry and Psychology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259
J Clin Psychiatry 74:1256-61. 2013..To determine if symptoms of depression accelerate in cognitively normal apolipoprotein E (APOE) ε4 carriers as compared to noncarriers...
- Looking toward DSM-V: should factitious disorder become a subtype of somatoform disorder?Lois E Krahn
Department of Psychiatry and Psychology, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
Psychosomatics 49:277-82. 2008..Although patients may not be conscious of their motivation or even their behaviors, deliberately embellishing history or inducing symptoms exemplifies behaviors designed to enhance a self-concept of being ill...